Evidence map›Paper›PMID 36813872›Full record

ArticleScientific reports2023

Molecular identification and antiprotozoal activity of silver nanoparticles on viability of Cryptosporidium parvum isolated from pigeons, pigeon fanciers and water.

Rasha M M Abou Elez, Amira S A Attia, Hala M N Tolba, Reham G A Anter, Ibrahim Elsohaby

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. WaterborneJournal of water and health · 2024
    Pooled it
  2. Article
  3. Article
  4. Clinical cases ofJournal of veterinary research · 2026
    Article
  5. Article
  6. Article
  7. In Vitro Effects of Vanadate Erbium/Silver Oxide (ErVOVeterinary medicine and science · 2025
    Article
  8. Intestinal parasites of domestic pigeons (Journal of parasitic diseases : official organ of the Indian Society for Parasitology · 2025
    Article
  9. Article
  10. Nanoparticle Lysis ofMethods and protocols · 2024
    Article
  11. Article
  12. SilversolPharmaceutics · 2024
    Article
  13. Journal of advanced veterinary and animal research · 2023
    Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 3 countries.

Rasha M M Abou ElezDepartment of Zoonoses, Faculty of Veterinary Medicine, Zagazig University, Zagazig City, Sharkia, 44511, Egypt. rmmohamed@zu.edu.eg.
Amira S A AttiaDepartment of Veterinary Public Health, Faculty of Veterinary Medicine, Zagazig University, Zagazig City, Sharkia, 44511, Egypt.
Hala M N TolbaDepartment of Avian and Rabbit Medicine, Faculty of Veterinary Medicine, Zagazig University, Zagazig City, Sharkia, 44511, Egypt.
Reham G A AnterDepartment of Parasitology, Faculty of Veterinary Medicine, Zagazig University, Zagazig City, Sharkia, 44511, Egypt.
Ibrahim ElsohabyDepartment of Animal Medicine, Faculty of Veterinary Medicine, Zagazig University, Zagazig City, Sharkia, 44511, Egypt.
Zagazig University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cryptosporidium is a protozoan that causes acute gastroenteritis, abdominal pain, and diarrhea in many vertebrate species, including humans, animals and birds. A number of studies have reported the occurrence of Cryptosporidium in domestic pigeons. Thus, this study aimed to identify Cryptosporidium spp. in samples collected from domestic pigeons, pigeon fanciers, and drinking water, as well as to investigate the antiprotozoal activity of biosynthesized silver nanoparticles (AgNPs) on the viability of isolated Cryptosporidium parvum (C. parvum). Samples were collected from domestic pigeons (n = 150), pigeon fanciers (n = 50), and drinking water (n = 50) and examined for the presence of Cryptosporidium spp. using microscopic and molecular techniques. The antiprotozoal activity of AgNPs was then assessed both in vitro and in vivo. Cryptosporidium spp. was identified in 16.4% of all examined samples, with C. parvum identified in 5.6%. The highest frequency of isolation was from domestic pigeon, rather than from pigeon fanciers or drinking water. In domestic pigeons, there was a significant association between Cryptosporidium spp. positivity and pigeon's age, droppings consistency, housing, hygienic and heath conditions. However, Cryptosporidium spp. positivity was only significantly associated with pigeon fanciers' gender and heath condition. The viability of C. parvum oocysts was reduced using AgNPs at various concentrations and storage times in a descending manner. In an in vitro study, the highest reduction in C. parvum count was observed at the AgNPs concentration of 1000 µg/mL after a 24 h contact time, followed by the AgNPs concentration of 500 µg/mL after a 24 h contact time. However, after a 48 h contact time, a complete reduction was observed at both 1000 and 500 µg/mL concentrations. Overall, the count and viability of C. parvum decreased with increasing the AgNPs concentration and contact times in both the in vitro and in vivo studies. Furthermore, the C. parvum oocyst destruction was time-dependent and increased with increasing the contact time at various AgNPs concentrations.

Indexed as

Antiprotozoal AgentsCryptosporidiosisCryptosporidiumCryptosporidium parvumDrinking WaterMetal NanoparticlesAnimalsColumbidaeFecesHumansOocystsSilverAntiprotozoal AgentsDrinking WaterSilver

Identifiers

PMID36813872
PMCPMC9946930
OpenAlexW4321480351

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.